Lipsman Joshua B MD New York City, NY - 10016

Lipsman Joshua B MD is categorized under Physical Medicine, Physician/Surgeon in New York City, NY and active since 2010.

Lipsman Joshua B MD was established in 2010, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Physical Medicine, Physician/Surgeon business, which does work in the B2C market, and is classified as a Physical Medicine, Physician/Surgeon, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Joshua Lipsman at the company’s single location by writing to 155 East 29th St, New York City, New York NY 10016 or by phoning (212) 689-7185. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Lipsman Joshua B MD
Contact Person: Joshua Lipsman
Address: 155 East 29th St, New York City, New York 10016
Phone Number: (212) 689-7185
Annual Revenue (USD): $500.000 to $999.999
Founded: 2010
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Physical Medicine, Physician/Surgeon
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Lipsman Joshua B MD was started in 2010 to provide professional Physical Medicine, Physician/Surgeon under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact Joshua Lipsman for inquiries that concern Lipsman Joshua B MD by calling the company number (212) 689-7185, as your correspondence is most welcome. Additionally, the physical location of the single location of Lipsman Joshua B MD can be found at the coordinates 40.743058,-73.981367 as well as the street address 155 East 29th St in New York City, New York 10016.

For its online presence, you may visit Lipsman Joshua B MD’s website at and engage with its social media outlets through on Twitter and on Facebook.